Rare diseases
Investigational molecules
Locations
Study on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer
DenmarkStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
DenmarkStudy of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyCarboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease
FranceStudy of vinorelbine and cisplatin with radiation therapy for patients with castration- and taxane-resistant prostate cancer
EstoniaStudy on Vinorelbine for Patients with Metastatic Colorectal Cancer
ItalyStudy on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features
BelgiumStudy on Treosulfan and Melphalan for High-Risk Ewing Sarcoma Patients
ItalyStudy on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
AustriaDurvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalySacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
AustriaStudy on the Safety and Effectiveness of Methotrexate and Drug Combination for Children and Young Adults with High-Risk Metastatic Medulloblastoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
